SEC Form 4 · accession 0001209191-15-024156
AVANOS MEDICAL, INC. · AVNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher G. Isenberg
Officer — See Remarks
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F1 | $45.47 | Mar 5, 2015 | A | 2,379 | A | Mar 5, 2018 | Mar 5, 2025 | Common Stock | 2,379 | 7,135 | D |
| Employee Stock Options (right to buy)F1 | $45.47 | Mar 5, 2015 | A | 2,378 | A | Mar 5, 2019 | Mar 5, 2025 | Common Stock | 2,378 | 7,135 | D |
| Employee Stock Options (right to buy)F1 | $45.47 | Mar 5, 2015 | A | 2,378 | A | Mar 5, 2020 | Mar 5, 2025 | Common Stock | 2,378 | 7,135 | D |
Explanation of responses
- F1Line items with the same expiration date represent all sub-parts of the same option grant, but reflect the various vesting dates of the options.
Remarks
Senior Vice President - Global Supply Chain and Procurement